Showing results (11-20 of 63) with videos related to
Sort By:
Pageof 7
American Health & Drug Benefits|December 21, 2020
Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs for Patients with Newly Diagnosed Systolic versus Diastolic Heart FailureChi Nguyen, Xian Zhang, Thomas Evers, et al.Federal Practitioner : for the Health Care Professionals of the VA, Dod, and PHS|February 16, 2019
Predictors of Hemoglobin A<sub>1c</sub> Goal Attainment in Patients Treated With Insulin at a VA Pharmacist-Managed Insulin ClinicDiane E Hadley, Alice L Scaletta, Casmir I Ogbonna, et al.Clinical Therapeutics|March 31, 2021
Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage PopulationJay Visaria, Chioma Uzoigwe, Caroline Swift, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 13, 2006
Hypoglycemic events and glycosylated hemoglobin values in patients with type 2 diabetes mellitus newly initiated on insulin glargine or premixed insulin combination productsMichael F Bullano, Maxine D Fisher, W Daniel Grochulski, et al.Journal of the American Pharmacists Association : Japha|May 24, 2013
Spirometry: tool for pharmacy practitioners to expand direct patient care servicesMichael J Cawley, Jean Moon, Jennifer Reinhold, et al.Patient Preference and Adherence|May 10, 2023
Patient Perspectives on the Burden of Heart Failure with Preserved Ejection Fraction in a US Commercially Insured and Medicare Advantage Population: A Survey StudyChi Nguyen, Luke Bamber, Vincent J Willey, et al.Current Medical Research and Opinion|April 2, 2005
Differences in hypoglycemia event rates and associated cost-consequence in patients initiated on long-acting and intermediate-acting insulin productsMichael F Bullano, Ibrahim S Al-Zakwani, Maxine D Fisher, et al.Journal of Health Economics and Outcomes Research|March 23, 2026
Retrospective Analysis of Burden of Illness of Congenital Pulmonary Valve Disease in a Large, Commercially Insured US PopulationTariku J Beyene, Vincent J Willey, Malvika Venkataraman, et al.Health Affairs (Project Hope)|May 14, 2008
Costs of severely ill members and specialty medication use in a commercially insured populationVincent J Willey, Michael F Pollack, Wayne M Lednar, et al.Medical Care|April 28, 2006
Agreement between administrative claims and the medical record in identifying patients with a diagnosis of hypertensionMichael F Bullano, Siddhesh Kamat, Vincent J Willey, et al.Pageof 7